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Available online 24 March 2008AbstractIndividual informed consent is a key ethical obligation for clinical studies, but empirical studies show that key requirements are
often not met. Common recommendations to strengthen consent in low income settings include seeking permission from commu-
nity members through existing structures before approaching individuals, considering informed consent as a process rather than
a single event, and assessing participant understanding using questionnaires. In this paper, we report on a qualitative study exploring
community understanding and perceptions of a malaria vaccine trial (MVT) conducted in a rural setting on the Kenyan Coast. The
MVT incorporated all of the above recommendations into its information-giving processes. The findings support the importance of
community level information-giving and of giving information on several different occasions before seeking final individual con-
sent. However, an emerging issue was that inter-personal interactions and relationships between researchers and community mem-
bers, and within the community, play a critical role in participants’ perceptions of a study, their decisions to consent or withdraw,
and their advice to researchers on study practicalities and information to feedback at the end of the trial. These relationships are
based on and continually tested by information-giving processes, and by context specific concerns and interests that can be difficult
to predict and are well beyond the timescale and reach of single research activities. On the basis of these findings, we suggest that
the current move towards increasingly ambitious and stringent formal standards for information-giving to individuals be counter-
balanced with greater attention to the diverse social relationships that are essential to the successful application of these procedures.
This may be assisted by emphasising respecting communities as well as persons, and by recognising that current guidelines and
regulations may be an inadequate response to the complex, often unpredictable and ever shifting ethical dilemmas facing research
teams working ‘in the field’.
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Open access under CC BY license.Informed consent in international biomedical
research settings
Individual informed consent is a key ethical obliga-
tion for clinical studies, but empirical studies show
that key requirements are often not met. Problems
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getting participants to fully understand and accept the
facts and their implications; overcoming patient fear
of reproach if they do not conform to doctors’ requests;
reluctance of doctors and participants to acknowledge
uncertainties in modern medicine; a difficulty in tran-
scending patients’ trust in medicine and their doctors;
over-emphasis on the legal as opposed to moral aspects
of consent; and insensitivity and authoritative handling
of vulnerable people by doctors). These challenges
can be compounded in international research environ-
ments by relatively big differences between investiga-
tors and community members in levels of formal
education, in access to good quality biomedical ser-
vices, and in values, priorities and understandings of
health and illness (Benatar, 1994; Doumbo, 2005; Ema-
nuel, Wendler, Killen, & Grady, 2004; Leach & Fair-
head, 2005; Qiu, 1993). Underlying these differences
are global and local inequities in access to information
and resources (Benatar, 2002).
Most guidelines continue to recommend informed
consent in low income settings; the majority of ethical
committees retain it as a key requirement (CIOMS,
2002; NCOB, 2002; WMA), and it is now a matter of
law in the European Union (EU, 2006). Recommended
adaptations include preceding individual consent with
community level consultation and permission, typically
through existing structures of authority such as chiefs,
community and religious leaders, and schools. Where
the majority of potential participants cannot read or
write, alternative methods of documenting the individ-
ual informed consent process such as using audio or
video tape might also be considered. Further sugges-
tions for improving informed consent, many of which
are not unique to low income settings, are (Allmark,Ma-
son, Gill, &Megone, 2003; Edwards, Lilford, Thornton,
& Hewison, 1998; Fitzgerald, Marotte, Verdier, John-
son, & Pape, 2002; Kass, Maman, & Atkinson, 2005;
Marshall, 2006;Mitchell, Nakamanya, Kamali, &Whit-
worth, 2002; Molyneux, Peshu, & Marsh, 2004; Simin-
off, 2003; Smyth & Weindling, 1999):
 Allowing for shorter, more simplified wording in
consent forms, as much of the detail currently re-
quested in consent forms is designed to protect re-
searchers and their institutions rather than research
participants;
 Considering informed consent as a process rather
than a one-off exercise, and as part of a wider com-
munity engagement process;
 Incorporating visual aids and simple verbal tests,
or quizzes, into informed consent processes; Carrying out preliminary or concurrent social sci-
ence research to check understanding and identify
local issues and concerns to consider in informa-
tion-giving activities;
 Careful participatory training of fieldworkers
(FWs) in communication skills and ethics; and
 Considering ‘assent’ only on admission, or devel-
oping a ‘step-like’ or ‘continuous’ consent process
for emergency situations.
In this paper, we report on community understand-
ing of and perceptions surrounding the informed con-
sent processes of a malaria vaccine trial (MVT)
conducted in a rural setting on the Kenyan Coast.
The MVT is one study carried out by the KEMRI/
Wellcome Trust Research Programme. This is a large
multi-disciplinary research programme with two
closely linked ‘Units’ e Nairobi and Kilifi. The re-
search programme and how it is perceived by the lo-
cal resident population are described in detail
elsewhere (Marsh, Kamuya, Gikonyo, Rowa, &
Molyneux, 2008; Molyneux et al., 2004; Molyneux,
Peshu, & Marsh, 2005; Molyneux, Wassenaar, Peshu,
& Marsh, 2005). Included in previous papers are in-
formation on understanding of research details of
three studies, which appeared low, and on rumours
and concerns including surrounding blood volumes
and use, and the need for clearer employment
policies.
The MVT was selected for this study because we
have not previously looked at perceptions and under-
standing of a vaccine trial, because the information-giving
practices included many of the recommendations made
locally and in the literature, and because FWs from the
study villages were employed to live in the villages
over the study period. The more common practice in
our institution at the time was to employ staff from
across the district to work on a series of studies; usu-
ally resulting in their being resident in Kilifi town
and making daily visits from the research centre to
study households. For the MVT study, two senior
FWs, with prior experience of clinical trials, were
based in Kilifi town, to supervise 10 FWs resident in
the study area.
The aims of the community perceptions study pre-
sented in this paper were to:
1. document participants’ understanding and con-
cerns at the point of recruitment into the MVT;
2. explore community members’ views about the
MVT, the amount of information given, and the
consent processes followed;
710 C. Gikonyo et al. / Social Science & Medicine 67 (2008) 708e7203. gather community members’ expectations and
inputs into information for feedback and methods
to use at the end of the MVT; and
4. gather community member and staff perceptions
on the pros and cons of having field-based inter-
viewers working on community-based studies.
In the following sections we describe the MVT in
more detail, followed by the methods and key findings
corresponding to the above objectives. The study was
not designed to explore social relationships, but their
importance throughout the findings is clear, and re-
turned to in the discussion as an emerging issue.
The malaria vaccine trial e overview and infor-
mation-giving procedures
The MVT centred on two candidate vaccines FP9
ME-TRAP and MVA ME-TRAP, used in sequence.
The trial aimed to document the vaccines’ safety, im-
munogenicity and efficacy against febrile malaria in
400 children using a double blind randomised con-
trolled trial (with rabies vaccine as the control). The
study procedures are summarised in Box 1 (see also
Bejon et al., 2006). Parents were encouraged to contact
field staff based in the study villages in the case of any
illness in study participants. The FW could then com-
municate with the PI by mobile phone in the case of an
emergency, or directly with the dispensary, to ensure
the child received treatment. This was free of charge
for the one year study period. The MVT used
a multi-step informed consent process, summarised in
Box 2. Each step was used to respond to issues raised
at the previous step. All preliminary information-giv-
ing activities were held within 3 months, and were sup-
ported by distributing information sheets in the local
languages. The entire process, including consent forms
and information sheets, had been reviewed in advanceBox 1. Summary of MVT procedures
 Preliminary health check/screening at the local
stool sampling, height and weight measureme
identification on subsequent visits.
 For children whose parents consented, and who
ministration in three injections over three subseq
1 h after each vaccination to observe for any im
 Daily check-ups for 3 days, and one week, after
 After the last vaccination, all children treated fo
 Weekly home visits to monitor for malaria for on
3 months and at one year.by a consent committee at the unit, as well as the na-
tional and international Institutional Review Boards.
Methods
Participant understanding and perceptions of MVT
were explored through two main activities, both of
which were conducted by interviewers independent
of the trial team (members of the institution’s Social
and Behavioural Research Group, or ‘SBR’).
Exit interviews/quiz
A quiz passed by the local and national ethics re-
view committees had initially been incorporated into
step four of the above information-giving process.
For the purposes of this study, the quiz was imple-
mented as an exit interview with two sections: (a)
open-ended questions seeking basic information on
where the person learned about the MVT, what they
liked/did not like about the study and reasons for join-
ing; and (b) open-ended questions checking the under-
standing of key issues that had been dealt with during
the informed consent process. Exit interviews were
conducted with 189 caretakers after the consenting
and screening processes. The quiz was administered
at the last possible moment to avoid disrupting the
screening process. Issues that were raised by partici-
pants were referred to trial staff to ensure that partici-
pants did not leave with prominent concerns.
Individual interviews and focus group discussions
Individual interviews were held with the PI and se-
nior FWs working on the MVT, but based in Kilifi
(n¼ 3). Group discussions were held with the FWs
based in the study area (n¼ 2) and with community
members who consented to be in the study (n¼ 9).dispensary, including blood-taking, urine and
nts, and a physical check. A photograph for
were well enough to participate, vaccine ad-
uent visits to the dispensary. Children stay for
mediate side-effects.
each vaccination.
r malaria, and a blood test taken.
e year, including blood sample collection after
Box 2. Summary of MVT information-giving processes
 PI and his team met with local dispensary committee and local administration to seek permis-
sion to conduct the study in the area and to discuss the study details and practicalities.
 A series of large community sensitisation meetings in each of the specific villages. These were
public meetings already organised by local leaders, attended by the PI and fieldworkers. There
was an oral presentation of the study aims and design, and information sheets were distrib-
uted. Questioning of the PI and FWs by the community and community representatives was
encouraged.
 MVT fieldworkers made individual visits to homesteads to discuss the study in more detail and
to invite parents to bring their children to the local dispensary for further information and,
should they choose to consent, for screening.
 At the dispensary, the MVT information was repeated to parents in groups as they arrived, and
then to individual parents before they signed consent and the screening/health check was
done. Time was given for questioning and discussion at both the group and individual stage.
 A further, brief explanation was given prior to administration of the vaccine, which occurred at
least one week after giving consent.
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the initial consenting process and almost halfway
through the trial. All community group participants
were female, and their children had received all three
vaccinations. Focus Group Discussions (FGDs) ex-
plored issues around objectives 2e4 above. The
FGDs were held until a ‘point of saturation’ was
reached and no new information was being collected
(de Negri & Thomas, 2003). The discussions were con-
ducted in the local dialect, tape-recorded, transcribed
and translated into English.
Exit interview answers were grouped and entered in
Foxpro and frequencies produced using SPSS version
11.5. A detailed thematic framework was developed
and applied to the qualitative data by the first author
and checked by the last author and an independent col-
league. Quotations presented in this paper have been
selected to illustrate typical or particularly illustrative
comments made under the main themes that emerged.
In a separate paper, we discuss community reactions to
the exit interview/quiz itself in more detail (Molyneux,
Gikonyo, Marsh, & Bejon, 2007).
Findings
Community understanding of the MVT and reasons for
joining and staying
Of the 189 exit interviews, 91% were with the par-
ticipant’s mother, 2% with fathers and 7% with other
caregivers, primarily aunts and grandmothers. These
figures reflect the general picture of those bringingchildren to the dispensary for the screening and vac-
cine visits. Of quiz respondents, 40% said the mother
decided on the child’s involvement, 19% said both par-
ents and 18% the father alone. In some cases, it was
reported that the father simply informed the mother
to take the child to the dispensary and enrol him or
her, without informing the mother why or what the
project was about.
The proportion of participants with correct re-
sponses ranged from 29 to 85%, depending on the
question (Table 1). The proportion reporting they do
not know ranged from 14 to 45%. This suggests very
variable levels of knowledge for different and even
highly related key sets of information, and some major
gaps in understanding. However, our interview ques-
tions may not have fully captured participant under-
standing; because of the tool itself, or the way and
point at which it was administered. In FGDs, for exam-
ple, comments suggested that many parents did under-
stand that the study was a malaria vaccine trial. Hints
of this understanding were sometimes found when dis-
cussing other issues. For example, as one mother said
when discussing study benefits:
About one month ago my child experienced fever
and vomited yellow and her stool was yellow, so I
don’t know if she was given the rabies or the ma-
laria vaccine because she still has problems. and
that vaccine is still being tested to see if it can pro-
tect against malaria or not (KI; P12; page 12).
The trial was generally described as some form of as-
sistance; as a project aimed at ensuring good health in
Table 1
Correct and don’t know answers on key vaccine trial information
(quiz)
Questions Correct
response
(%)
Stating
DK
(%)
What is this research for? 35 26
Why vaccine can’t be given to all Kenyan
children at the moment?
48 45
If your child is healthy, and take part, how
many injections will they receive?
49 31
Will all children be given a malaria vaccine? 85 16
Why will you have to stay at the clinic for
1 h after the injection?
80 14
Will children who have received a vaccine
be able to get malaria?
29 44
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This was true also for those who apparently understood
the research aims of the trial. Linked to this finding, the
main reasons for joining and staying in the study were
reported by most to be the individual benefits associated
with the study such as free treatment, transport to and
from Kilifi District Hospital in the case of any illness,
and access to the PI (who is medically qualified). These
individual benefits were repeatedly highlighted over any
altruistic interest in contributing to the global pool of
knowledge on malaria prevention:
What attracted us [was that] we knew our children
will receive treatment for a whole year in every dis-
ease they suffer. If you have a problem and visit the
people concerned, a call is made to the . [PI] he
brings a vehicle and [the sick person] is carried
away [to hospital]. In fact it’s something we should
be happy about because nobody can bring you a ve-
hicle that easily. (G1; P11; page 11).
In some cases, the decision to join the study had less
to do with the any of the study details (scientific or
practical) than with previous encounters with, and con-
fidence in, the research centre:
I had another baby who suffered epilepsy and some
white people were registering epileptic children. A
time came when they invited me 3 times to take
her there giving me fares and other free offers. it
was ages ago. and people in my home said ‘all
those free offers?, you’d better not go!’. But I
went. and the baby took drugs, her condition got
better and now she’s OK. So now, when this
KEMRI activity about malaria came, I saw no prob-
lem. I hurriedly went and underwent their processes
(KI; P7; page 16).Concerns with the study
Of the quiz respondents, 22% expressed at least one
concern about the vaccine trial or KEMRI. This was
not on direct questioning, but emerged in the process
of administering the quiz. Most concerns (44%) were
related to the vaccine (fear of side-effects, that it was
a trial vaccine, that they were not being told which vac-
cine their child was getting, and that the vaccine was
not being given to all children). Other concerns were
about the blood samples (21%), why photographs
were being taken (16%), rumours circulating in the
community (described below), whether there was to
be HIV testing, and personal concerns (9% each).
Most personal concerns were from mothers who were
worried about their husbands’ reaction when they
found out that the mother had enrolled the child/ren
without the father’s consent. Most of these mothers re-
ported wondering what would happen if the father de-
cided to withdraw the child.
These concerns were mirrored in the FGDs. Most were
voiced as concerns of the community, and linked to ru-
mours about KEMRI being a ‘devil worshipping organisa-
tion’. Reported bases for these rumours are summarised in
Box 3, with several often mentioned together as follows:
P8: It is said that we joined KEMRI and photo-
graphs were taken, blood was removed and both
will be taken there [to KEMRI]. later they will
cut the photo up and the child will start fitting
P3: Yes, the child will fit [i.e., have a seizure]
[laughter]. and die. so KEMRI are devil wor-
shippers (M2; page 3).
Some participants said that other people became
particularly fearful when they heard or read about the
side-effects detailed in the information sheet. Such ru-
mours and concerns were reported as the main reasons
behind non-participation and drop-outs, and to flare up
when rumours appeared to be being proven true:
At the time [of the first vaccine being adminis-
tered]... One of us went in while her child was
asleep and got the injection. [The child] continued
to sleep even after coming out of the room. A
mother among us said, ‘Aaaahh the child has
fainted!’ That is when many started to .withdraw.
It was the first group.The first group created all
these problems. (M1; P2; page 20).
When asked about their own concerns now, it
appeared that there was some concern that the devil
worshipping rumours may yet be proven true:
Box 3. Reported bases of ‘devil worshipping’ rumours
 Blood sampling: are volumes taken not dangerous? what is done with it? where does it go?
 Fear of whites: Why are they here? Have they returned to re-colonise us? They have ‘their own
complexities’ ‘they’re not trusted’, ‘they have jinis (demons)’
 Distribution of free things: ‘we’ve always had health problems why come now? what can their
motivation be? why give sodas, juices, bread? why visit people in their homes even at
midnight?’
 Other screening procedures: are the measurements of a child’s height and head circumference
taken as part of the initial health check actually measurements for the child’s coffin? Can pho-
tographs be taken away and used to cause harm to the child from elsewhere?
 A failure or refusal by rumour-mongers to listen to or internalise study information; and
 Ultimately, a fear that children will later lose their good health, get paralysed, fit or die.
1 This was a multiple response question.
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P4: It’s a conflict between those who attended and
those who didn’t, so it’s upon us to educate them
so that they don’t convince the ones participating
to withdraw.
P8: When they see us boarding the free vehicles
they shout ‘a lazy person takes advantage of any
chance’ (M2; pages 4e8).
.the [vaccine] for malaria is still new in our place
that’s why they are doing it [the trial] using our chil-
dren. And a lot of nonsense has been going round.
We are fighting to cross over [to truly believing
that all of the rumours are nonsense] but after [the
trial] you should think about us because we are in
the middle of water (laughter) [i.e., the ones taking
the risks] we don’t know whether we’ll drown or
what . we are in the middle of the sea. (K2; P2;
page 24)
The above comments suggest that many rumours
were being spread by non-participants because of in-
tra-community conflicts and jealousies centring on
the trial. By the time of the discussions, participants
appeared to have the upper hand: they were enjoying
the free treatment provided as part of the trial and
none of the rumours had yet been proven true. In all
groups, there was mention of non-participants regret-
ting their decision and participants telling them that
they were too late. Others talked of non-participants
coming to borrow drugs for their sick children, in
some cases being told off by participants. Nevertheless,
there was often some indication of continued concern
in what was often described as their journey with their
research team: ‘‘.even though we have worries, we
cannot drop-out now because we have alreadyjoined.’’; or ‘‘in a traffic accident, the driver dies
with the passengers’’. Everyone expressed hope that
at the end of the study, their concerns would be allevi-
ated and their decision to remain participants appreci-
ated by the study team and envied by non-participants.
The information-giving process for the study
During the quiz, 35% of the caregivers reported
hearing about the vaccine trial during community
meetings, 34% from vaccine trial field assistants visit-
ing their homesteads, 21% from relatives and neigh-
bours, and 6% from the local dispensary.1 Most
(58%) said that they learned most when they came
for the screening and a fifth that information from all
sources was equally important.
In FGDs, there was strong support for each of the
stages followed in the information-giving process.
The involvement of the local chief, elders and dispen-
sary committee at the outset was described as essential
for an outside group or individual entering the local
community:
P7: [It was] good because he passed through the
government; we saw him first with the chief. That
made us feel peaceful because he was with the
chief, a village elder and our hearts were clean be-
cause we know if any bad thing befalls us, we’ll first
get hold of the chief or the village elder to solve that
problem (K1, P3/7, page 19).
Information-giving at the individual household level
was described as offering greater opportunity for dis-
cussion and ensuring husbands were included in infor-
mation and decision-making processes:
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by women who are usually ‘yes’ people and so
things sometimes go wrong in their hands. But in
the homestead you can find the husband. if he
comes to listen he’ll have questions and after all
[the questions] have been answered, that’s when
a decision will be made.
P10: .I went to the meetings and was visited at
home. That gave me the motivation to go to the dis-
pensary and find out even more and to decide there
if I like it I’ll enrol my child, if not I won’t (K1;
page 23).
Specifically and regularly mentioned was the PI’s
presence, his efforts to speak the local languages, and
their ability to question him directly about the study.
Overall, parents reported that the community had
been well informed about all aspects of the study be-
fore it began, and that people joined of their own
free will knowing that they could withdraw whenever
they wished. Of particular note was apparent apprecia-
tion of having been informed of ‘the good and bad
sides’ of the study before joining (i.e., the benefits vs
side-effects). In general, there were no suggestions
about what more could have been done to alleviate
rumours beyond proving them wrong, because ‘one in-
dividual cannot clean another person’s heart’.
General disadvantages raised in the FGDs regarding
the informed consent process were that the side-effects
and the voluntary nature of the participation were over-
emphasised, and the signing of the consent form itself.
These emphases were viewed by some as the project or
KEMRI protecting themselves should anything happen
to participants (e.g., KEMRI not being blamed if there
were severe side-effects):
We were explained to and understood that it wasn’t
a must. It was a personal decision. You agree then
the child goes in for screening. We were asked at
least three times. Just like when you see someone
preaching on the roadside you may think he is
mad but he’s not, you just think s/he is because
you don’t know what is in the bible. For us who
are . [in the study] we understand [the risks and
benefits] (laughs). [We understand that it’s] just
like in a vehicle accident where your friends might
die and you survive, so we are in because we made
that decision. (J2; P13; page 8)
Then you are told to put your signature and after
signing your child will be vaccinated. now you
have put a noose around your neck. you cannot
free yourself (G1; P2; page 10).In FGDs with fieldworkers, one argued that on the
MVT consent form the ‘.[commitment from the PI]
did not have the same weight as the [parent’s] one
that says ‘‘I, (so and so), being the mother of this child,
have given out my child to be researched on’’. The
view expressed here, by someone who administers
the forms, is that the signing of the consent form indi-
cates a binding, unequal commitment, despite wording
on the form itself to the contrary.
Having locally employed and based FWs working on
the vaccine trial
Having locally employed and based FWs was seen
as positive both for the project and for the community
for several reasons.
 They knew the area very well, and how to talk to,
reassure and explain the study to people; helping
them understand, and making recruitment faster
and easier.
 The close proximity of the FWs, constant surveil-
lance by the team and ease of communication over
the follow-up period were important benefits to
participants; and
 It was satisfying to see that KEMRI had created
employment in the area.
FWs were aware of their importance for the project.
As one put it, ‘‘we could have spoilt or made the mradi
[project] because people in my village were asking
questions’’. They also had to respond to unexpected is-
sues and questions as they arose, in some cases on the
basis of little training. Some responses may have been
more appropriate than others. Compare for instance the
ideas on how to respond to community concerns about
devil worship (Box 4).
There were also problems associated with FWs be-
ing part of the community. For example, rumours about
relationships between mothers and FWs were
mentioned:
P8: The way [the FWs] are free with us; they can
visit in the morning or evening to check on the
kid. [So non-participants] have now started spread-
ing rumours that they are not only KEMRI but our
boyfriends.
P7:.[they say] ‘Is he the only doctor in this area?’
. and that thing of sending him children even at
night for treatment they see that as our excuse to
visit him: ‘Where was she going at that hour? Going
to her boyfriend’. (Laughter) (M2; page 13/14).
Box 4. Examples of FWs responses to parents’ concerns about devil worship
I would explain that the blood from your child alone cannot be enough for devil worshippers be-
cause devil worshippers would need an amount maybe a glass size or more. [P2; page 6].
You know in my area there were few people with such rumours and I tried to explain to them
that KEMRI is an organisation which was started lawfully by the Kenyan parliament so this is
not a thing that the government doesn’t know and also.the local leaders have been consulted
[goes on to explain the historical reasons for the logo which was apparently fuelling rumours]
[P10; page 8].
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fieldworkers in forming the link between local commu-
nities and much needed health care, the intra-commu-
nity jealousies and tensions that can result from those
who are included and excluded from these research-
related benefits, including employment itself, and the
difficulties FWs face in their daily interactions at the
interface.
Expectations regarding information to feedback at the
end of the study
During the FGDs, three sets of expectations
emerged regarding informational feedback.
The first, often referred to as ‘jambo la kwanza’
(the first thing) was to inform the participants about
whether the vaccine was found to be working or
not, and which children received which vaccine (ra-
bies or malaria). The second was results of all tests
done over the follow-up period on individual partici-
pants, information on whether children had received
the rabies or malaria vaccine, and a report on the
child’s health status since receiving the vaccine. The
need for simple answers, and the desire for a positive
finding, was clear. In all groups, it was noted that
should the findings be successful, it would reduce
worries and concerns about the vaccine, and about
the project and KEMRI in general and reduce the
teasing and rumours from non-participants. In all
groups, there were also references to negative feelings
or reactions if the study was to fail, especially if any
rumours regarding the dangers of the study were
proven true:
where there is a trial, there is either success or fail-
ure.so for example if it fails, we all will be in
agony.True. We’ll start complaining, directing
our complaints to [the PI] (K1; various; page 43).In most groups, there were requests for informa-
tion in large meetings rather than to individuals or
small groups, ‘otherwise there’ll be misunderstand-
ings with people saying different results were given
to different people’. There was also a call for separate
feedback meetings for the general community and for
the participants’ parents. In some groups, it was ex-
pressed strongly that non-participants should not get
any feedback from the team but should wait and get
it second-hand from participants. One participant em-
phasised that non-participants should get the finding
‘that makes them feel bad’. The importance of in-
ter-personal interaction as part of feedback was
stressed:
because these information sheets you are giving out
can either be ignored or considered as mere paper to
hide the truth from us. someone can also read
from the sheet and misunderstand it completely
(M2; page 34/35).
Third, all groups mentioned being concerned about
participants being forgotten once the study is over and
requested some form of recognition from the PI or
KEMRI for their role and the risks and inconveniences
they have gone through: recognition ranging from
a simple public thank you and acknowledgement, to
being given something (‘so the PI does not benefit
alone’), to major demands (e.g., building a dispensary
near them). Other requests included having a KEMRI
employed clinician at the local dispensary to cater spe-
cifically for those who participated in the study, field
assistants being given enough drugs to last at least
one year, and further studies in the area.
‘‘.but he should not succeed and gowhilewe’ve been
together with him. Now, we should be given [pres-
ents] openly such that those that did not consent for
the study should feel bad.’’ (K1; various; page 39).
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a way of having the vaccine put in the KEPI (Kenya
Expanded Programme on Immunisation) schedule
and information on whether participants could partici-
pate in another trial in the future. Some wondered
whether they would be forced to pay for the vaccine
once it was made available to all and recommended
that there be a way of participants receiving free
vaccinations.
Discussion
Information-giving processes and understanding
Measuring understanding is far from straightfor-
ward. The proportion of respondents giving correct re-
sponses differed even for highly related questions in
our exit interviews, and comments made in FGDs sug-
gested far greater overall understanding of key study de-
tails. The difficulty of measuring understanding, and in
particular, of distinguishing between recognition, recall
and comprehension, is well recognised. Lindegger et al.
(2006), for example, found differences in levels of un-
derstanding among the same individuals using four dif-
ferent methods of assessment. They suggested these
differences were linked to both under- and over-
reporting in response to different types of assessment,
and to the methods accessing qualitatively different as-
pects of the ‘construct called ‘understanding’’ (p 565).
In our study, we believe on the basis of FGDs that
respondents’ concern about the information being
sought, and the relative formality of the process, may
have led to an increased number of ‘do not knows’
for some exit interview questions. For example, if par-
ents are being asked (in what was described as a rather
intimidating individual ‘exam’ setting), what an activ-
ity is about, and are concerned about whether or not
they have been told the truth, they may answer ‘don’t
know’ in the hope of being given new information to
confirm or ease any doubts they have (i.e., cross-checking
the trial staff). Furthermore, being asked the questions
by a similar yet separate group may itself raise con-
cerns about the activity, particularly in a context of
rumours circulating in the community, and with the rel-
ative novelty of the procedures and social relationships
involved in being in a trial. Our findings may also be
related to inadequate probing by fieldworkers to
open-ended responses, and possibly our posing ques-
tions to mothers bringing their children to the dis-
pensary rather than to other household members,
particularly husbands and household heads (see also
below). These methodological issues and theirimplications are described in greater detail elsewhere
(Molyneux et al., 2007).
The above complexities and limitations aside, partic-
ipants clearly felt adequately informed about key aspects
of the vaccine trial, and overall, understanding of the
study appeared greater than we have previously ob-
served (Molyneux et al., 2004). This may be attributed
to several factors including (1) the support of experi-
enced local staff in carefully designing informed consent
forms, and in the broader information-giving processes;
(2) the continuous presence of fieldworkers and the PI in
the community, facilitating the building up of rapport
between research staff and community members, and
quick awareness of and response to emerging issues;
(3) the nature of the MVT trial itself, in that it involves
well people away from a clinical setting, and a tangible
experimental design rather than a more abstract basic
science question; and (4) because we explored under-
standing relatively soon after the intensive information
campaigns and administration of the vaccines. There
were some informational gaps or misinterpretations,
for example, what exactly would happen to the blood,
why individual results were not being given for every
blood test taken over the one-year period, which vaccine
was being tested, and several more unusual concerns
such as whether children given the rabies vaccine would
later bark. However, many of these sets of information
would not generally be included in research information
sheets, could not easily be predicted in advance, and
were responded to once raised.
Of note are two issues. Firstly, levels of perceived
risk as illustrated in rumours and concerns were often
far greater and more dramatic than the biomedical risks
outlined in consent forms. Information-giving proce-
dures can both contribute to and ease these rumours
and concerns, as described in greater detail below.
However, the perceived benefits, including free fol-
low-up and treatment of study participants for one
year, were also perceived to be substantial. This is not
surprising given the significant costs that illnesses pres-
ent to households (Chuma, Thiede, & Molyneux,
2006). Secondly, and mainly in response to these issues,
the main reason people agreed to the study was the very
real health benefits that participants and their families
would receive, rather than the hope that the vaccine
would work. This is common in settings where research
activities can come to be considered one of the range of
treatment options for families, each of which has its ad-
vantages and disadvantages (Leach & Fairhead, 2005).
Study participants were generally supportive of all of
the study information-giving procedures. While there
may be rather ambivalent views in the community about
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ognition and acceptance of the local administration and
elders, typicallymale, is clearly perceived to be essential
to the legitimacy of a study before taking any further
steps (Molyneux, Wassenaar, et al., 2005), supporting
the inclusion of these structures in information-giving.
Regarding public community meetings, these are an ac-
cepted and widely practised step to entering local com-
munities for all organisations on the Coast, and were
considered by all to be an important channel for ex-
changing information. Discussing the risks and benefits
in detail in these forums risks increasing the spread of
concerns, rumours and raised expectations in the com-
munity, but also enables these issues to be openly dis-
cussed and resolved. We believe that the amount of
public information-giving required and its impact will
depend on the specific study and context, and will be
of interest to explore in future studies.
Visits to households are another important step in
helping ensure that complex intra-household decision-
making dynamics are respected. As we have described
elsewhere (Molyneux, Murira, Masha, & Snow, 2002),
males and elders generally have the stated judicial au-
thority for economic and health matters in Mijikenda
(the dominant ethnic group on the Kenyan Coast) house-
holds, while women are almost entirely responsible for
supportive care. The extent to which males and elders
exert their influence appears to depend on type of house-
hold (for example, rural or urban, nuclear or extended,
interactions between households); the woman’s age,
education and income earning role; the specific
relationship she has with her husband; what is being de-
cided upon; and who is available or can be made avail-
able at the time a decision is needed. Overall, the more
‘risky’ a situation, the more important it is to have the
household head, and other elders who are not necessarily
the primary caretakers, involved.Given the experimental
nature of theMVT, and the unfamiliar procedures and re-
lationships involved, enabling potential participants to
consider the study information and implications with
other householdmemberswas crucial.Our exit interview
findings on understanding may have been influenced by
those being interviewed not being the main decision-
makers around the child’s participation, nor the most
knowledgeable within the household about the trial.
We cannot confirm this given our study design and the
difficulty inmeasuring understanding (described above).
Rumours, relationships and trust
While there was an overall appreciation of the study
details and the information-giving proceduresfollowed, it is clear that participants receive (mis)infor-
mation about the study and the research institution
from other sources too. This information can conflict
with or exaggerate study team information, and is often
described as ‘rumours’. Examples circulating within
the community at the time of our FGDs were around
the levels and types of risks related to the blood-taking,
vaccines, and other procedures such as photographs
and measurement of children in wards. The most
prominent were rumours that children would die at
the point of being vaccinated, over the course of the
study, or even long after the completion of the trial,
as a result of witchcraft. Similar rumours have been re-
peatedly reported across Africa, and should be taken
seriously both as a real concern, and as an expression
of uncertainty, tension and ethical comment in field
settings (Geissler & Pool, 2006). Their strength for
communities lies in the difficulty of confronting them
by simply re-stating the scientific facts or supplement-
ing explanations with demonstrations. There were
strong feelings in our study that rumours were being
fuelled and spread by non-participants, and that they
may have been inadvertently supported by field-
workers’ own explanations and responses to unex-
pected questions. What information people chose to
believe about the study, associated rumours, percep-
tions of risks and benefits, and decisions regarding
whether or not to join the study, are related to prag-
matic interests in treatment and to trust. Trust is a rela-
tional notion, describing a voluntary relationship
between two or more people (inter-personal trust) or
between a person and an institution (institutional trust)
(Gilson, 2003). For some individuals trust in the vac-
cine trial and in the information given out by trial staff
was automatically transferred from previous positive
interactions with the institution or its staff. Similarly,
some of the concerns and rumours were less to do
with the vaccine trial information, than to a general
distrust in KEMRI and outsiders.
It appears for many that the vaccine trial informa-
tion-giving process was important not so much for en-
suring understanding of study details as for following
local rules, helping clear possible misconceptions and
fears, and for developing relationships and exhibiting
behaviours such as truthfulness, concern, and fairness,
that are known to be supportive of trust building (Gil-
son, 2003; Mechanic & Meyer, 2000). Incorporating
into the study team both external technical competence
(the PI) and internal inter-personal competence (locally
known and based field assistants who are ‘our family’,
and ‘who understand us and we can approach’) ap-
peared to be critical. In some cases, the levels of trust
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reached were well beyond the aims of the PI. These
findings indicate that care is required not to exploit
trust once this is established (Molyneux, Wassenaar,
et al., 2005). The findings also support the work of
others (Elbourne, Snowdon, & Garcia, 1997; Kuczew-
ski & Marshall, 2002) who argue the inadequacy of tra-
ditional models of informed consent based on subjects
or their proxies making sound, competent, thoughtful
and rational choices on the basis of the information
given. Some level of fragility in the trust that is built,
and an element of enduring scepticism, is essential
for the proper functioning of informed consent pro-
cesses. In our setting this balance was illustrated in
the reportedly heavy reliance on observation and expe-
rience to decide what information was the truth (‘see-
ing is believing’), and by apparently sudden concerns
and changing of minds by whole groups of potential
participants if activities or incidents suggested any
truth in the circulating rumours. This situation also il-
lustrates the complex and constantly shifting relation
between and within research and community groups.
Discussions around what was expected at the end of
the study re-emphasised the importance of inter-per-
sonal relations and trust, and the fragility of both.
While there was a clear interest in finding out the trial
outcome, there was also a desire to prove rumour-mon-
gers wrong, and to find out what would happen if
‘KEMRI’s children’ suffered future problems. Most ev-
ident here were the intra-community tensions, jealou-
sies and feelings of superiority that were woven into
those interests. Thus reasons given for needing feed-
back, and particularly positive feedback, included
making non-participants regret their decision not to
be involved and to absolve those who had aligned
themselves with the study team. The latter was often
described as a major commitment and show of trust
given the repeated efforts from some community mem-
bers to undermine their decision. Occasionally, the lo-
cal FW e seen as a key connection point in the alliance
between participants and KEMRI staff, and generally
praised for his/her general assistance in the vaccine
trial e was threatened when the possibility of negative
findings were raised by group discussion participants:
‘‘. let us pray that the year ends without any bad
incident and new year starts nicely but in case one
child dies who is in their group. [FW threatened]
(M2; p 37).
Therewas clearly a concern that the benefits and priv-
ileged status of participants vis-a`-vis non-participants
should not be ended suddenly, particularly the regularsurveillance of children’s health. As was described in
one group, if you do so ‘‘we’ll become a laughing stock’’
(M2; P12; p 32). Such comments show how community
members can contribute to debates on locally appropri-
ate ethical practice, including around appropriate levels
of benefits for participation andwhat to dowhen a trial is
over.
The above findings suggest that participation in re-
search can contribute to the forming of new types of
social relationships or even new ‘communities’ (i.e.,
‘groups of people with diverse characteristics who are
linked by social ties, share common perspectives and
engage in joint action in geographical locations or set-
tings’ (MacQueen et al., 2001, p 1936). Fieldworkers
based ‘in the field’ can also play an important role in
the establishment, maintenance and nature of these
communities, and can contribute to and be impacted
on by relationships between these communities. Ex-
ploring these issues, and more specifically the meaning
of membership in communities of ‘trial participants’
and ‘non-participants’, their relative importance over
other social networks and over time, tensions and shifts
between them, and how membership is sought, main-
tained and ended in each, was beyond the scope of
our study. Such information would require more indi-
vidual in-depth interviews and ideally a more thorough
immersion and residence in the community itself. The
data would be invaluable not only to informing
information-giving processes, but also to better under-
standing the experiences and consequences e and,
therefore, ethical implications e of research activities.
Conclusions
Our findings illustrate that inter-personal interac-
tions and relationships between researchers and com-
munity members, and within the community, are
critical to participants’ perceptions of and decisions
to join or leave a study. Responsive community en-
gagement activities, including careful informed con-
sent procedures, can help identify and respond to
emerging issues, and build trusting relationships that
are supportive of positive perceptions and informed
participation. However, these relationships are also
based on and continually tested by concerns and inter-
ests that can be difficult to predict, or that are well be-
yond the timescale and reach of single research
activities. Fieldworkers at the interface between re-
search groups and communities have a particularly
key and often difficult role in establishing and main-
taining these interactions and relationships. Their crit-
ical role in ethical practice at the field level through
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ethical comments, raised through, for example, ques-
tions, concerns and rumours, is often under-recognised
and under-supported.
We have highlighted in our discussion some areas
that would benefit from further in-depth exploration,
and from comparison in other settings and by other
study types. Nevertheless, we would counter-balance
the current move towards increasingly ambitious and
stringent formal standards for individual information-
giving and checking, with a call for greater attention
to the social relationships that are clearly affected by
and essential to the success of these procedures. In so
doing, we support others (Weijer & Emanuel, 2000;
Weijer, Goldsand, & Emanuel, 1999) in emphasising re-
spect for communities as well as persons, and in recog-
nising that current guidelines and regulations are an
inadequate response to the complex, often unpredict-
able and ever shifting ethical dilemmas facing re-
searchers ‘in the field’ (Mitchell et al., 2002). In
Kilifi, we are strengthening our efforts to respond to
these issues through the development and implementa-
tion of a communication strategy, including community
engagement activities. These initiatives, and the
dilemmas and lessons we have learned to date, are de-
scribed in detail elsewhere (Marsh et al., 2008). These
papers not only offer practical ideas that we believe
have been valuable in our setting, but also illustrate
that striving for improved ethical practice will always
be challenging, incomplete, and involve complex and
open processes of discussion, interaction and negotia-
tion between parties with diverse interests.
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